Axsome (AXSM) Ends Patent Dispute, Stock Surges On Positive News
Axsome Therapeutics, Inc. (NASDAQ: AXSM) stock price surged 23.46% on the charts to $130.58 on the announcement of a settlement of a patent dispute with Teva Pharmaceuticals. All pending litigation pertaining to its AUVELITY (dextromethorphan HBr – bupropion HCl) product is resolved by the agreement. Settlement of the Patent Conflict The case started when Teva …
Axsome (AXSM) Ends Patent Dispute, Stock Surges On Positive News Read More »